The javascript used on this site for creative design effects is not supported by your browser. Please note that this will not affect access to the content on this web site.
Skip Navigation
U.S. Department of Health and Human Services
  • YouTube
  • HRSA eNews
  • Print this
  • Email this


Federal Register Notices | Policy Releases | Manufacturer Notice Forms | Section 340B of the Public Health Service Act | Monthly Program Updates

Manufacturer Discounts in the 340B Program Offer Benefits, but Federal Oversight Needs Improvement (GAO) September 2011
(PDF - 1.53 MB)

State Medicaid Policies and Oversight Activities Related to 340B Purchased Drugs (OEI-05-09-00321) June 2011 (PDF - 733.7 KB)

Unit of Measure Inconsistencies in the Medicaid Prescription Drug Program (OEI-05-07-00050) November 2007 (PDF - 823.2 KB)

Review of 340B Prices (OEI-05-02-00073; 07/06) July 2006
(PDF - 815.51 KB)

Deficiencies in the Oversight of the 340B Drug Pricing Program (OEI-05-02-00072) October 2005 (PDF - 1.28 MB)

Deficiencies in the 340B Drug Discount Program's Database (OEI-05-02-0071) June 2004 (PDF - 520.4 KB)

Review of Hemophilia Treatment Centers' Disposition of Program Income and Patient Choice for Factor Provider for Calendar Year 2000 (A-03-01-00350) June 2003 (PDF - 451.4 KB)

Pharmaceutical Manufacturers Overcharged 340B-Covered Entities (A-06-01-00060) March 10, 2003 (PDF - 416.2 KB) 

Cost Containment of Medicaid HIV/AIDS Drug Expenditures (OEI-05-99-00611) July 2001 (PDF - 877.2 KB)

AIDS Drug Assistance Program Cost Containment Strategies (OEI-05-99-00610) September 2000 (PDF - 302.9 KB)

Audit of the Mashantucket Pequot Tribal Nation's Use of Federal Discount Drug Programs (A-01-99-01502) August 2000
(PDF - 2.02 MB)

Audit of Comprehensive Hemophilia Treatment Centers' Utilization of the Public Health Service 340B Drug Pricing Program (A-01-98-01505) December 10, 1999 (PDF - 791.6 KB)

Audit of the Utilization of the Public Health Service 340B Drug Pricing Program (A-01-98-01500)  
July 1998
(PDF - 169.3 KB)

Audit of State AIDS Drug Assistance Programs' Use of Drug Price Discounts (A-01-97-01501) January 1998 (PDF - 2.87 MB)

Report to Congress on Extending the P.L. 102-585 Drug Pricing Program to Selected PHS Block Grant Recipients (1993) (PDF - 2 MB)

Program Integrity

340B Drug Pricing Program covered entities must ensure program integrity and maintain accurate records documenting compliance with all 340B Program requirements.

Covered entities are subject to audit by manufacturers or the federal government. Failure to comply may make the 340B covered entity liable to manufacturers for refunds of discounts obtained.

Learn more: Program Integrity

Contact the 340B Prime Vendor Program

340B Prime Vendor Program website
1-888-340-2787 (Monday – Friday, 9 a.m. – 6 p.m. ET)